Table 5 Mean and standard deviation (SD) costs, mean and SD quality-adjusted life years (QALYs), mean differences and incremental cost-effectiveness ratios during the trial follow-up period for intervention vs control groups (secondary analyses)
Intervention mean (SD) | Control mean (SD) | Mean difference (95% CI) per patient | P value | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Costs | ||||||||||
Intervention (A) | ||||||||||
Hospital utilization (B) | ||||||||||
Medical benefits (C) | ||||||||||
Pharmaceuticals (D) | ||||||||||
Patient costs (E) | ||||||||||
Total cost health system (A + B + C + D) | (1) | |||||||||
Total cost societal (A + B + C + D + E) | (2) | |||||||||
QALYs | (3) | |||||||||
Incremental cost effectiveness ratio (ICER) | ||||||||||
Health system perspective | (1)/(3) | |||||||||
Societal perspective | (2)/(3) | |||||||||